Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus
- PMID: 7872181
- DOI: 10.1016/0002-8703(95)90278-3
Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus
Abstract
The purpose of this study was to determine the prevalence and progression of pulmonary hypertension over a 5-year follow-up period in 28 patients with systemic lupus erythematosus (SLE) who were originally enrolled in an echocardiographic study of pulmonary hypertension in 1985 and 1986. Twenty healthy volunteers without cardiac or pulmonary disease participated as normal controls. Each patient and control underwent a complete Doppler echocardiographic study. Doppler echocardiographic recordings of tricuspid insufficiency, with saline contrast enhancement when necessary, were used to calculate pulmonary artery systolic pressure according to the modified Bernoulli equation. Doppler echocardiographic measurement of cardiac output was performed at rest for each subject, and pulmonary resistance was calculated by dividing the pulmonary artery systolic pressure by the cardiac output. These results were compared to results of the original studies to detect serial changes in pulmonary pressure and pulmonary resistance; results were also compared to the group of normal controls. The prevalence of pulmonary hypertension increased from 14% at the first study to 43% at follow-up. A significant increase in mean systolic pulmonary artery pressure was detected in the SLE patients during the follow-up period: 23.4 vs 27.5 mm Hg (p < 0.005). In addition, a significantly higher pulmonary artery pressure was detected in the SLE patients compared with the normal controls (p < 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Pulmonary hypertension in systemic lupus erythematosus.J Rheumatol. 1989 Jul;16(7):918-25. J Rheumatol. 1989. PMID: 2769664
-
[Increased pulmonary artery stiffness and its relation to right ventricular function in patients with systemic lupus erythematosus].Turk Kardiyol Dern Ars. 2008 Mar;36(2):82-9. Turk Kardiyol Dern Ars. 2008. PMID: 18497552 Turkish.
-
Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Prevalence and Predictors.J Rheumatol. 2016 Feb;43(2):323-9. doi: 10.3899/jrheum.150451. Epub 2015 Dec 15. J Rheumatol. 2016. PMID: 26669915
-
[Severe pulmonary hypertension in systemic lupus erythematosus. The successful therapy of an unusual manifestation].Dtsch Med Wochenschr. 1999 May 21;124(20):618-23. doi: 10.1055/s-2007-1024557. Dtsch Med Wochenschr. 1999. PMID: 10370384 Review. German.
-
Obesity and Pulmonary Hypertension.Curr Hypertens Rep. 2018 Oct 5;20(12):99. doi: 10.1007/s11906-018-0899-2. Curr Hypertens Rep. 2018. PMID: 30291516 Review.
Cited by
-
Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus.Eur Respir Rev. 2011 Dec;20(122):277-86. doi: 10.1183/09059180.00003811. Eur Respir Rev. 2011. PMID: 22130821 Free PMC article. Review.
-
Respiratory Manifestations in Systemic Lupus Erythematosus.Pharmaceuticals (Basel). 2021 Mar 18;14(3):276. doi: 10.3390/ph14030276. Pharmaceuticals (Basel). 2021. PMID: 33803847 Free PMC article. Review.
-
[Cardiovascular monitoring of patients with systemic lupus erythematosus].Z Rheumatol. 2005 Nov;64(8):564-75. doi: 10.1007/s00393-005-0668-x. Z Rheumatol. 2005. PMID: 16328762 German.
-
Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension.Clin Rheumatol. 2006 Nov;25(6):866-72. doi: 10.1007/s10067-006-0206-5. Epub 2006 Feb 22. Clin Rheumatol. 2006. PMID: 16496078
-
[Pulmonary arterial hypertension in collagenoses].Z Rheumatol. 2009 Oct;68(8):630-2, 634-8. doi: 10.1007/s00393-009-0480-0. Z Rheumatol. 2009. PMID: 19593574 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical